VEGFA and metabolic dysfunction-associated steatotic liver disease: In line with this, Yu et al. [15] found that selenoprotein P was upregulated in NAFLD and obese patients, resulting in an inhibition of vascular endothelial growth factor (VEGF)-induced cell proliferation, renal tubule formation, and cell migration.